MENLO PARK, Calif., Feb. 3, 2023 /PRNewswire/ -- Ablacon, Inc., an Ajax Health and Zeus Health-backed developer of an innovative mapping system to guide the treatment of atrial fibrillation (AF), ...
Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development for the treatment of ...
Objective To assess the feasibility of conducting a cluster randomised controlled trial comparing the effects of Advanced ...
For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including ...
An expert from the FDA explained the benefits and limitations of these two clinical trial formats and how the cancer field can learn from both. The use of single-arm trials, in which all patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback